John Alexander Kelly, CFO of Precision Biosciences DTIL, has filed 4 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $101.1K. The latest trade was on 06/01.

JK

JK

John Alexander Kelly

CFO

Company

Precision Biosciences DTIL

First filing

23/01/24

Trades

50 trades

Buys / sales

4 / 4

12-month net buying

−$101.1K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Precision BiosciencesDTIL	Open-market sale10b5-1 plan	02/18	02/19	8,149 sh	$3.84	$31,292.16	−6.1%
Precision BiosciencesDTIL	Open-market sale10b5-1 plan	01/21	01/22	15,213 sh	$4.03	$61,308.39	−12.5%
Precision BiosciencesDTIL	Open-market sale10b5-1 plan	25/11/03	25/11/04	1,303 sh	$6.49	$8,456.47	−1.7%
Precision BiosciencesDTIL	Open-market sale10b5-1 plan	25/07/03	25/07/08	14,827 sh	$4.26	$63,163.02	−16.8%
Precision BiosciencesDTIL	Open-market buy	24/12/27	24/12/31	2,113 sh	$4.75	$10,036.75	+5.5%
Precision BiosciencesDTIL	Open-market buy	24/11/21	24/11/21	3,000 sh	$6.76	$20,280	+8.6%
Precision BiosciencesDTIL	Open-market buyAmendment	23/08/18	23/10/27	90,000 sh	$0.48	$43,200	+30.7%
Precision BiosciencesDTIL	Open-market buy	23/03/17	23/03/21	20,000 sh	$0.86	$17,200	+8.9%